JP2013509423A5 - - Google Patents

Download PDF

Info

Publication number
JP2013509423A5
JP2013509423A5 JP2012537052A JP2012537052A JP2013509423A5 JP 2013509423 A5 JP2013509423 A5 JP 2013509423A5 JP 2012537052 A JP2012537052 A JP 2012537052A JP 2012537052 A JP2012537052 A JP 2012537052A JP 2013509423 A5 JP2013509423 A5 JP 2013509423A5
Authority
JP
Japan
Prior art keywords
phenyl
methyl
alkyl
group
oxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012537052A
Other languages
English (en)
Japanese (ja)
Other versions
JP5815542B2 (ja
JP2013509423A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/054445 external-priority patent/WO2011059731A1/en
Publication of JP2013509423A publication Critical patent/JP2013509423A/ja
Publication of JP2013509423A5 publication Critical patent/JP2013509423A5/ja
Application granted granted Critical
Publication of JP5815542B2 publication Critical patent/JP5815542B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012537052A 2009-10-29 2010-10-28 Dpp−1阻害剤として有用なアルキニル誘導体 Expired - Fee Related JP5815542B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25617109P 2009-10-29 2009-10-29
US61/256,171 2009-10-29
PCT/US2010/054445 WO2011059731A1 (en) 2009-10-29 2010-10-28 Alkynyl derivatives useful as dpp-1 inhibitors

Publications (3)

Publication Number Publication Date
JP2013509423A JP2013509423A (ja) 2013-03-14
JP2013509423A5 true JP2013509423A5 (enExample) 2013-12-19
JP5815542B2 JP5815542B2 (ja) 2015-11-17

Family

ID=43503067

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012537052A Expired - Fee Related JP5815542B2 (ja) 2009-10-29 2010-10-28 Dpp−1阻害剤として有用なアルキニル誘導体

Country Status (7)

Country Link
US (1) US8633322B2 (enExample)
EP (1) EP2493571B1 (enExample)
JP (1) JP5815542B2 (enExample)
CN (1) CN102596321B (enExample)
AU (1) AU2010319927B2 (enExample)
ES (1) ES2513291T3 (enExample)
WO (1) WO2011059731A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012119941A1 (en) 2011-03-04 2012-09-13 Prozymex A/S Peptidyl nitrilcompounds as peptidase inhibitors
EP2825533B1 (en) 2012-03-13 2016-10-19 Basf Se Fungicidal pyrimidine compounds
AR091858A1 (es) 2012-07-25 2015-03-04 Sova Pharmaceuticals Inc INHIBIDORES DE CISTATIONIN-g-LIASA (CSE)
CA2923101A1 (en) 2013-09-16 2015-03-19 Basf Se Fungicidal pyrimidine compounds
WO2015036059A1 (en) 2013-09-16 2015-03-19 Basf Se Fungicidal pyrimidine compounds
EP4497473A3 (en) 2020-08-26 2025-04-23 Haisco Pharmaceuticals Pte. Ltd. Nitrile derivative that acts as inhibitor of dipeptidyl peptidase 1 and use thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US548021A (en) * 1895-10-15 Wiiitfield potter toomee
US4847241A (en) * 1985-08-14 1989-07-11 G. D. Searle & Co. Fluorenyl substituted tyrosyl dipeptide amides which are useful in treating pain
CA2099994C (en) 1991-03-06 2003-05-20 Robert B. Garland Phenyl amidines derivatives useful as platelet aggregation inhibitors
US5424334A (en) 1991-12-19 1995-06-13 G. D. Searle & Co. Peptide mimetic compounds useful as platelet aggregation inhibitors
DE4321502A1 (de) 1993-06-29 1995-01-12 Bayer Ag Alkinol-substituierte Peptide, Verfahren zu ihrer Herstellung und ihre Verwendung als antiretrovirale Mittel
AU6490396A (en) 1995-07-14 1997-02-18 Smithkline Beecham Corporation Substituted-pent-4-ynoic acids
NZ318926A (en) 1995-08-30 1999-04-29 Searle & Co Alpha v beta 3 integrin (vitronectin) inhibitors or anatagonists derived from benzoic acid for treating diseases of cell adhesion
JP2002145897A (ja) 2000-11-10 2002-05-22 Kyorin Pharmaceut Co Ltd アミノ酸誘導体及びその製造法
CA2480378A1 (en) * 2002-05-07 2003-11-20 Neurosearch A/S Novel azacyclic ethynyl derivatives
DE60226906D1 (de) * 2002-07-31 2008-07-10 Ranbaxy Lab Ltd 3,6-disubstituierte azabicyclo ä3.1.0ühexanderivate, die sich als muscarinrezeptorantagonisten eignen
US20040186151A1 (en) * 2003-02-12 2004-09-23 Mjalli Adnan M.M. Substituted azole derivatives as therapeutic agents
AU2004210711B2 (en) * 2003-02-12 2010-07-08 Transtech Pharma, Inc. Substituted azole derivatives as therapeutic agents
US20070155803A1 (en) * 2003-05-30 2007-07-05 Prozymex A/S Protease inhibitors
US7638513B2 (en) * 2004-06-02 2009-12-29 Schering Corporation Compounds for the treatment of inflammatory disorders
DE102005009784B4 (de) * 2005-03-03 2009-06-18 Technische Universität Darmstadt Peptid-Mimetika, Verfahren zur deren Herstellung, diese enthaltende pharmazeutische Zusammensetzung und deren Verwendung als Inhibitoren von Proteasomen und zur Induktion von Apoptose
KR20080004550A (ko) * 2005-03-30 2008-01-09 콘포마 세러퓨틱스 코포레이션 Hsp90-억제제로서 알키닐 피롤로피리미딘 및 관련유사체
BRPI0708942A2 (pt) 2006-03-21 2011-06-14 Joyant Pharmaceuticals Inc composto promotor de apoptose, uso e mÉtodo de produÇço do mesmo e composiÇço farmacÊutica
US7678894B2 (en) 2007-05-18 2010-03-16 Helicos Biosciences Corporation Nucleotide analogs
TW200922556A (en) 2007-08-20 2009-06-01 Glaxo Group Ltd Novel cathepsin C inhibitors and their use
BRPI0820665A2 (pt) 2007-12-12 2018-05-29 Astrazeneca Ab compostos de peptidil nitrilas, processos para fabricação dos mesmos, composição farmacêutica, combinação e uso de ditos compostos

Similar Documents

Publication Publication Date Title
JP2013509423A5 (enExample)
CA2554642A1 (en) Bicyclic carbonyl amino derivatives as chemokine receptor antagonists
JP2010540525A5 (enExample)
JP2014511892A5 (enExample)
JP2016506387A5 (enExample)
TWI410410B (zh) Phenylacetic acid compounds
JP2015145426A5 (enExample)
RU2001124567A (ru) Производные индола и их применение в качестве антагонистов мср-1
JP2014530900A5 (enExample)
PE20040892A1 (es) Antagonistas del receptor muscarinico m3 de acetilcolina
JP2016528302A5 (enExample)
JP2009526821A (ja) 注意欠陥多動性障害治療用の新規な医薬組成物
JP2010511626A5 (enExample)
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
RU2018136888A (ru) Нафтиридины в качестве антагонистов интегрина
NO20071193L (no) Fluorsubstituerte sykloalkanoindoler og deres anvendelse som prostaglandin D2-reseptorantagonister
JP2010077141A5 (enExample)
JP2011509309A5 (enExample)
UA110012C2 (uk) Лікарські форми для перорального застосування, що містять ацетат лікарбазепіну
JP2010504343A5 (enExample)
CN110062757A (zh) 凝血因子XIa抑制剂及其用途
RU2008151761A (ru) Производные имидазоазепинона
JP2010519216A (ja) Ccr5拮抗薬のための医薬組成物および方法
JP2023076632A5 (enExample)
JP2017222722A5 (enExample)